Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

248
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
248
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

211
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
211
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
T Cell Types and Functions01:24

T Cell Types and Functions

1.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.3K
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

3.3K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

188
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
188

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Financial Education and Coaching on Economic Stability in Low Income, Single Mother Families.

Journal of prevention (2022)·2026
Same author

Effect of a Financial Education and Coaching Program for Low-Income, Single Mother Households on Child Health Outcomes.

Healthcare (Basel, Switzerland)·2024
Same author

Time in Nature: A Prescription for the Prevention or Management of Hypertension.

American journal of lifestyle medicine·2023
Same author

Potential Benefit of Vitamin D Supplementation in COVID-19.

American journal of lifestyle medicine·2023
Same author

Drug-Induced Microbiome Changes: Considerations in Pregnancy.

American journal of lifestyle medicine·2023
Same author

Vaccine Equity: Lessons Learned from the COVID-19 Pandemic.

American journal of lifestyle medicine·2022

Related Experiment Video

Updated: Aug 21, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

307

Potential Benefits of Curcumin in Rheumatoid Arthritis.

Megan Sotebeer1, Nicole D White2

  • 1School of Pharmacy and Health Professions, Creighton University, Omaha, NE, USA.

American Journal of Lifestyle Medicine
|November 17, 2022
PubMed
Summary

Curcumin, a compound found in turmeric, shows promise for treating rheumatoid arthritis by reducing inflammation and modulating immune cells. Further research is needed to confirm effective dosing and bioavailability for this natural anti-inflammatory agent.

Keywords:
Curcumininflammationrheumatoid arthritisturmeric

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

301
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.1K

Related Experiment Videos

Last Updated: Aug 21, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

307
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

301
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.1K

Area of Science:

  • Pharmacology
  • Immunology
  • Rheumatology

Background:

  • Curcumin, derived from turmeric, is traditionally used in Eastern Medicine for inflammatory conditions.
  • It is increasingly recognized for its potential therapeutic applications in modern medicine, particularly for rheumatoid arthritis.

Purpose of the Study:

  • To evaluate the clinical trial literature on curcumin's impact on rheumatoid arthritis patients.
  • To describe curcumin's mechanisms of action, bioavailability challenges, and optimal dosing strategies.

Main Methods:

  • Systematic review of clinical trial data.
  • Analysis of preclinical and clinical evidence on curcumin's anti-inflammatory and immunomodulatory effects.

Main Results:

  • Curcumin demonstrates anti-inflammatory properties by inhibiting pro-inflammatory cytokines.
  • It modulates the differentiation and function of B cells and T cells, key players in rheumatoid arthritis pathogenesis.

Conclusions:

  • Curcumin exhibits potential as a therapeutic agent for rheumatoid arthritis.
  • Further investigation into bioavailability and standardized dosing is crucial for clinical application.